0001877990-21-000002.txt : 20210812 0001877990-21-000002.hdr.sgml : 20210812 20210812093258 ACCESSION NUMBER: 0001877990-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210812 DATE AS OF CHANGE: 20210812 EFFECTIVENESS DATE: 20210812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Praesidia Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001877990 IRS NUMBER: 870985466 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-409716 FILM NUMBER: 211165719 BUSINESS ADDRESS: STREET 1: 1167 MASSACHUSETTS AVE. CITY: ARLINGTON STATE: MA ZIP: 02476 BUSINESS PHONE: 6692459489 MAIL ADDRESS: STREET 1: 1167 MASSACHUSETTS AVE. CITY: ARLINGTON STATE: MA ZIP: 02476 D 1 primary_doc.xml X0708 D LIVE 0001877990 Praesidia Biotherapeutics, Inc. 1167 MASSACHUSETTS AVE. ARLINGTON MA MASSACHUSETTS 02476 6692459489 DELAWARE None None Corporation true 2021 Sohang Chatterjee 1167 Massachusetts Ave. Arlington MA MASSACHUSETTS 02476 Executive Officer Director Pradip Majumder 1167 Massachusetts Ave. Arlington MA MASSACHUSETTS 02476 Executive Officer Martin Lehr 3675 Market St. #200 Philadelphia PA PENNSYLVANIA 19104 Director Shawn Titcomb 275 Commercial Blvd., Suite 333 Lauderdale by the Sea FL FLORIDA 33308 Director Biotechnology Decline to Disclose 06b false 2021-07-30 true true true Praesidia Biologics Inc. merged with and into Praesidia Biotherapeutics, Inc. prior to the offering. 0 Tribal Capital Markets, LLC 38901 None None 111 South Pineapple Ave., Suite 619 Sarasota FL FLORIDA 34236 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO FL FLORIDA IL ILLINOIS IN INDIANA MD MARYLAND MT MONTANA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS true 10000000 4000000 6000000 Total offering is $10,000,000, consisting of first tranche of $4,000,000 and second tranche of $6,000,000. false 55 700000 true 0 Payment of the sales commissions is contingent upon the sale of the full offering amount. 0 true Proceeds of the offering will be used for general working capital of the issuer, including payment of salaries to officers. false Praesidia Biotherapeutics, Inc. Sohang Chatterjee Sohang Chatterjee Chief Executive Officer 2021-08-12